This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Rubnitz JE, Pui C-H, Downing JR . The role of TEL fusion genes in pediatric leukemias Leukemia 1999 13: 6–13
Van Dongen JJ, Seriu T, Panzer-Grümayer ER, Biondi A, Pongers-Willemse MJ, Corral L, Stolz F, Schrappe M, Masera G, Kamps WA, Gadner H, van-Wering ER, Ludwig WD, Basso G, de Bruijn MA, Cazzaniga G, Hettinger K, van der Does van den Berg A, Hop WC, Riehm H, Bartram CR . Prognostic value of minimal residual disease in acute lymphoblastic leukemia in childhood Lancet 1998 352: 1731–1738
Panzer-Grümayer ER, Schneider M, Panzer S, Fasching K, Gadner H . Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia Blood 2000 95: 790–794
Pongers-Willemse MJ, Seriu T, Stolz F, d’Aniello E, Gameiro P, Pisa P, Gonzalez M, Bartram CR, Panzer-Grümayer ER, Biondi A, San Miguel JF, van Dongen JJM . Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets. Report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia Leukemia 1999 13: 110–118
Schrappe M, Reiter A, Sauter S, Ludwig WD, Wörmann B, Harbott J, Bender-Götze C, Dörffel W, Dopfer R, Frey E, Havers W, Henze G, Kühl J, Richter R, Ritter J, Treuner J, Zintl F, Odenwald E, Welte K, Riehm H . Konzeption und Zwischenergebnis der Therapiestudie ALL-BFM 90 zur Behandlung der akuten lymphoblastischen Leukämie bei Kindern und Jugendlichen: die Bedeutung des initialen Therapieansprechens in Blut und Knochenmark Klin Pädiatr 1994 206: 208–227
Zuna J, Hrusak O, Kalinova M, Muzikova K, Stary J, Trka J for the Czech Paediatric Haematology Working Group . TEL-AML1 positivity in childhood ALL: average or better prognosis? Leukemia 1999 13: 22–24
Acknowledgements
This work was supported in part by the ‘Österreichische Kinderkrebshilfe’ and by private donations to the CCRI. We thank M Konrad and S Fischer for excellent technical assistance, also the physicians B Ausserer, FM Fink, N Jones, G Müller, I Mutz, R Ployer, N Pobegen, K Schmitt and O Stöllinger for providing bone marrow samples. Production of the probes was supported by the Biomed 1 Concerted Action CT94-1703.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fasching, K., König, M., Hettinger, K. et al. MRD levels during the first months of treatment indicate relapses in children with t(12;21)-positive ALL. Leukemia 14, 1707–1708 (2000). https://doi.org/10.1038/sj.leu.2401882
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401882